P587: COVALENT-101: A PHASE 1 STUDY OF BMF-219, A NOVEL ORAL IRREVERSIBLE MENIN INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE LEUKEMIA, DIFFUSE LARGE B-CELL LYMPHOMA, AND M... by F. Ravandi-Kashani, A. Kishtagari, H. Carraway, G. Schiller, E. Curran, B. Yadav, A. Cacovean, S. Morris, T. Butler, J. Lancet

Get full text

P524: PHASE 1B/2 STUDY ON SAFETY, PK, PD, AND PRELIMINARY EFFICACY OF THE SELECTIVE SYK INHIBITOR LANRAPLENIB IN COMBINATION WITH THE FLT3 INHIBITOR GILTERITINIB, IN FLT3-MUTATED R... by E. M. Stein, A. Patel, L. C. Michaelis, G. Schiller, R. Swords, L. A. Carvajal, G. Bray, J. DiMartino, M. Y. Levy

Get full text

P1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTOR... by N. Jain, G. Roboz, M. Konopleva, H. Liu, G. Schiller, E. Jabbour, P. Desai, D. Whitfield, A. Haider, O. Zernovak, M. Frattini, C. Brownstein, R. Larson

Get full text

P1063: EFFICACY AND SAFETY OF PARSACLISIB-RUXOLITINIB COMBINATION THERAPY IN MYELOFIBROSIS PATIENTS WITH LOW VS HIGHER BASELINE PLATELET COUNT: A SUBGROUP ANALYSIS OF DATA FROM A P... by A. Yacoub, U. Borate, R. Rampal, H. Ali, E. Wang, A. Gerds, G. Hobbs, M. Kremyanskaya, E. Winton, C. O’Connell, S. Goel, S. Oh, G. Schiller, A. Assad, S. Erickson-Viitanen, F. Zhou, N. Daver

Get full text